News and interviews from Exagen Inc which trades on the NASDAQ under the symbol XGN. Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE® brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology.
Exagen Inc (NASDAQ: XGN)
Claim This Podcastby Exagen Inc
1 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
News and interviews from Exagen Inc which trades on the NASDAQ under the symbol XGN. Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE® brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology.
Language
🇺🇲
Publishing Since
5/31/2022
1 verified contact email on file for Exagen Inc (NASDAQ: XGN)
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 31, 2022
Exagen Inc President & CEO, Ron Rocca Interview with TodaysStocks.com Host, Pat Bolland
<p>Exagen Inc. (NASDAQ: XGN) is a patient-focused and discovery-driven commercial-stage life sciences company, that aids patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. A relentless pursuit for laboratory excellence has enabled Exagen to develop next-generation autoimmune testing to help empower physicians and improve patients' lives. </p> <p>Learn more about Exagen Inc on their website https://exagen.com/ </p> <p>================================================================= </p> <p>TodaysStocks.com Today's News for Tomorrows Investor </p> <p>Find out more @ https://todaysstocks.com/ </p> <p>Want to book a CEO Interview with Pat Bolland? Click here↓ </p> <p>https://stockmkt.info/3wQaurn </p> <p>Want to book a News Release Interview with Natalie Stoberman? Click here↓ </p> <p>https://stockmkt.info/3wRITY5 </p> <p>Follow us Facebook: https://www.facebook.com/TodaysStocksNow </p> <p>Follow us on Twitter: https://twitter.com/TodaysStocksNow </p> <p>________________________________________________________________ </p> <p>TodaysStocks.com does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of TodaysStocks.com and do not constitute investment advice. All readers and viewers are encouraged to perform their own due diligence.</p>
1 total episodes available
Deep-dive analytics for Exagen Inc (NASDAQ: XGN)
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Exagen Inc (NASDAQ: XGN)?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.